Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
CymaBay Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
CymaBay Therapeutics (CBAY) Prices $75M Share and Warrant Offering at $7/sh
-
CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
-
CymaBay Therapeutics (CBAY) Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants
-
CymaBay Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
CymaBay Therapeutics (CBAY) Prices $75M Share and Warrant Offering at $4/sh
-
CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
-
UPDATE: CymaBay Therapeutic (CBAY) PT Raised to 'Street High' $20 at Cantor Fitzgerald, Following Positive Seladelpar Results
-
Cantor Fitzgerald Said 'Just the Beginning' of CymaBay Therapeutic (CBAY) Share Recovery After FDA Hold Lifted
-
CymaBay Therapeutic (CBAY) PT Raised to $15 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Upgrades CymaBay Therapeutic (CBAY) to Overweight
-
After-Hours Movers 06/24: (ALDX) (GNFT) (USNA) Higher; (CNAT) (GMDA) (KRYS) (more...)
-
CymaBay Therapeutic (CBAY) Selloff Overdone - Cantor
-
CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Pre-Open Stock Movers 03/06: (ANF) (ZAYO) (AMBA) Higher; (VLRX) (CLDX) (PRMW) Lower (more...)
-
CymaBay Therapeutics (CBAY) Prices 8M Common Stock Offering at $12.50/Share
-
CymaBay Announces Pricing of Public Offering of Common Stock
-
CymaBay Therapeutics (CBAY) to Offer Common Stock
-
CymaBay Announces Proposed Public Offering of Common Stock
-
Pre-Open Stock Movers 09/20: (ALNY) (KPTI) (GEMP) Higher; (BBBY) (IONS) (GIS) Lower (more...)
-
After-Hours Stock Movers 09/19: (KOOL) (GEMP) (CBAY) Higher; (BBBY) (IOVA) (ADBE) Lower (more...)
-
Cantor Fitzgerald Starts CymaBay Therapeutic (CBAY) at Overweight
-
CymaBay Therapeutics to Present at Two Investor Conferences
-
CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
CymaBay Therapeutics (CBAY) Prices 13M Common Stock Offering at $6.50/Share
-
CymaBay Announces Pricing of Public Offering of Common Stock
-
CymaBay Therapeutics (CBAY) Announces 10M Share Common Offering
-
CymaBay Announces Proposed Public Offering of Common Stock
-
CymaBay Announces Participation at Cantor Fitzgerald Healthcare Conference on July 12th in New York
-
CymaBay Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference